z-logo
open-access-imgOpen Access
Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
Author(s) -
Alexander Afanasyev,
Alexander BogachevProkophiev,
Maksim Kashtanov,
Д. А. Астапов,
A.S. Zalesov,
Sergei A. Budagaev,
Ravil Sharifulin,
Э. М. Идов,
Sergei I. Zheleznev
Publication year - 2020
Publication title -
interactive cardiovascular and thoracic surgery
Language(s) - English
Resource type - Journals
eISSN - 1569-9293
pISSN - 1569-9285
DOI - 10.1093/icvts/ivaa075
Subject(s) - alcohol septal ablation , medicine , septal myectomy , cardiology , hazard ratio , hypertrophic cardiomyopathy , ventricular outflow tract , ablation , cumulative incidence , ventricular outflow tract obstruction , cardiomyopathy , confidence interval , surgery , heart failure , obstructive cardiomyopathy , cohort
OBJECTIVES There is very little evidence comparing the safety and efficacy of alcohol septal ablation versus septal myectomy for a septal reduction in patients with hypertrophic obstructive cardiomyopathy. This study aimed to compare the immediate and long-term outcomes of these procedures. METHODS Following propensity score matching, we retrospectively analysed outcomes in 105 patients who underwent myectomy and 105 who underwent septal ablation between 2011 and 2017 at 2 reference centres. RESULTS The mean age was 51.9 ± 14.3 and 52.2 ± 14.3 years in the myectomy and ablation groups, respectively (P = 0.855), and postoperative left ventricular outflow tract gradients were 13 (10–19) mmHg vs 16 (12–26) mmHg; P = 0.025. The 1-year prevalence of the New York Heart Association class III–IV was higher in the ablation group (none vs 6.4%; P = 0.041). The 5-year overall survival rate [96.8% (86.3–99.3) after myectomy and 93.5% (85.9–97.1) after ablation; P = 0.103] and cumulative incidence of sudden cardiac death [0% and 1.9% (0.5–7.5), respectively P = 0.797] did not differ between the groups. The cumulative reoperation rate within 5 years was lower after myectomy than after ablation [2.0% (0.5–7.6) vs 14.6% (8.6–24.1); P = 0.003]. Ablation was associated with a higher reoperation risk (subdistributional hazard ratio = 5.9; 95% confidence interval 1.3–26.3, P = 0.020). At follow-up, left ventricular outflow tract gradient [16 (11–20) vs 23 (15–59) mmHg; P < 0.001] and prevalence of 2+ mitral regurgitation (1.1% vs 10.6%; P = 0.016) were lower after myectomy than after ablation. CONCLUSIONS Both procedures improved functional capacity; however, myectomy better-resolved classes III–IV of heart failure. Septal ablation was associated with higher reoperation rates. Myectomy demonstrated benefits in gradient relief and mitral regurgitation elimination. The results suggest that decreasing rates of myectomy procedures need to be investigated and reconsidered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom